Lee Frank D. — SEC Form 4 filings
SEC reporting owner CIK 1814686. 12 Form 4 filings on record with FilingPulse; latest filed 2026-05-26.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-05-21 to 2026-05-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 8,264 shares, $99,994 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 40,368 shares, $254,682 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 24,456 shares @ $5.43 ($132,796) in Bausch Health Companies Inc., filed 2026-05-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Bausch Health Companies Inc. (BHC) | Director | 5 | — | 2 legs · 40,368 sh · $254,682 | 3 |
| Pacira BioSciences, Inc. (PCRX) | Chief Executive Officer, Director | 6 | 1 leg · 8,264 sh · $99,994 | — | 5 |
| Bolt Biotherapeutics, Inc. (BOLT) | Director | 1 | — | — | 1 |
Form 4 filings — Lee Frank D.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-26 | 4 | Bausch Health Companies Inc. (BHC) | Grant/award (A): 45,871 @ $0 | EDGAR |
| 2026-05-20 | 4 | Bausch Health Companies Inc. (BHC) | Sale (S): 24,456 @ $5.43 | EDGAR |
| 2026-02-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 261,818 @ $0 | EDGAR |
| 2026-02-03 | 4 | Pacira BioSciences, Inc. (PCRX) | Tax withholding (F): 41,488 @ $20.54 | EDGAR |
| 2026-01-06 | 4 | Pacira BioSciences, Inc. (PCRX) | Tax withholding (F): 9,272 @ $24.46 | EDGAR |
| 2025-08-22 | 4 | Bausch Health Companies Inc. (BHC) | Sale (S): 15,912 @ $7.66 | EDGAR |
| 2025-05-20 | 4 | Bausch Health Companies Inc. (BHC) | Grant/award (A): 54,347 @ $0 | EDGAR |
| 2025-02-04 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 350,000 @ $0 | EDGAR |
| 2025-01-06 | 4 | Pacira BioSciences, Inc. (PCRX) | Tax withholding (F): 9,375 @ $18.33 | EDGAR |
| 2024-08-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Purchase (P): 8,264 @ $12.10 | EDGAR |
| 2024-06-14 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | Bausch Health Companies Inc. (BHC) | Grant/award (A): 35,360 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1814686 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →